Need help choosing the right laser? Our engineers are standing by. Get Free Consultation

Solta Medical Thermage CPT TG-2B vs Fraxel: A Clinic Buyer's Honest Comparison

I've been handling device procurement for a med-spa clinic for seven years. I've personally made (and documented) 11 significant purchasing mistakes, totaling roughly $38,000 in wasted budget. Now I maintain our team's evaluation checklist to prevent others from repeating my errors.

One pattern keeps showing up: clinics treat the Solta Medical Thermage CPT TG-2B and the Fraxel as if they're interchangeable options competing for the same slot in the treatment menu. They aren't. But the purchasing pressure makes the comparison real. Here's the framework I wish I'd had in 2018.

Why these two get compared (and why the comparison matters)

Both are non-invasive. Both come from Solta Medical. Both get marketed under the "skin rejuvenation" umbrella. If you're expanding your treatment menu with one major device this year, these two end up on the same spreadsheet.

Here's how I now evaluate them — four dimensions, each compared directly:

  1. Technology and primary indication
  2. Patient experience (pain and downtime)
  3. Revenue and utilization
  4. Procurement reality (my expensive mistake)

One of these conclusions surprised me. I'll flag it when we get there.

Dimension 1: The technology — one heats, one resurfaces

Thermage CPT TG-2B

The Thermage CPT TG-2B uses monopolar radiofrequency to heat the deeper dermis to around 65–75°C. No ablation, no wounding. Collagen contracts immediately, and new collagen builds over 3–6 months. It's an RF skin tightening device in the purest sense.

Primary indication: mild-to-moderate laxity, especially on the face and neck. Think of it as the non-surgical maintenance option for patients who aren't ready for a facelift (and may never be).

Fraxel

Fraxel is a fractional laser platform with two main modes: non-ablative (1410nm and 1550nm) and ablative (1927nm). It creates microscopic treatment zones (MTZs) surrounded by healthy tissue, which speeds recovery. The Fraxel for acne scars indication is well-established — the 1550nm wavelength is particularly effective on textured scarring and pigmentation.

Primary indication: acne scars, sun damage, texture irregularities, fine lines, pigment.

Verdict on Dimension 1

Not substitutes — different tools. Thermage is "tighten." Fraxel is "resurface." If your patient base skews toward younger patients with texture and pigmentation complaints, Fraxel covers more ground. If you serve a 40–55 demographic worried about sagging, Thermage is the closer match.

Dimension 2: Patient experience — pain and downtime

Let me be direct here, because the brochures aren't.

Thermage hurts. Each pulse is a brief, deep heat spike. Most clinics use topical lidocaine plus oral pain management. Treatment time runs 60–90 minutes. Downtime is essentially zero — some transient redness, that's it.

Fraxel pain varies by settings. Non-ablative is manageable — a rubber-band-snap sensation. Ablative is more intense and needs stronger anesthesia. Downtime: 3–7 days of redness and swelling for non-ablative; 7–14 days for ablative.

Here's where patients ask the question I hear at least twice a week: "Is Clear+Brilliant painful?" — even when we're actually discussing Fraxel. Clear+Brilliant is Solta's gentler laser resurfacing option, and the comparison is inevitable. To set the record straight: Clear+Brilliant sits below both Fraxel settings on the discomfort scale. If a patient's real concern is pain tolerance, that matters. Ranked by discomfort: Clear+Brilliant < Thermage < Fraxel non-ablative < Fraxel ablative.

Verdict on Dimension 2

Thermage = sharper treatment pain, minimal downtime. Fraxel = gentler during treatment (at lower settings), longer recovery. If your patients are working professionals who can't disappear for a week, Thermage clears that bar more easily. If your patients will accept downtime for better outcomes, Fraxel delivers.

Dimension 3: Revenue and utilization — the counterintuitive one

Here's what surprised me. Thermage has enormous brand recognition — patients walk in asking for it by name. You'd assume it's the revenue winner. In my experience, it's not.

Thermage sessions price around $1,500–$3,500 depending on market and treatment area. One session, maintenance every 12–18 months. Fraxel runs $750–$1,500 per session, but the standard protocol is 3–5 sessions. The per-patient lifetime value on Fraxel packages is higher.

I got this wrong in 2019. We prioritized Thermage because of the name recognition. Utilization was strong — but the margin per treatment was thinner than projected once we factored consumables and the longer room time. We added Fraxel a year later, and it became our better profit center, largely because package pricing lifted the average ticket per patient visit.

Verdict on Dimension 3

If your market is currently fixated on jawline and neck tightening, Thermage will generate faster payback. If your positioning leans toward acne scarring and overall texture, Fraxel probably wins on a 18–24 month horizon. No universal answer — it maps to your patient population.

Dimension 4: Procurement reality — the $4,000 mistake

In 2021, we tried to source a refurbished Thermage CPT TG-2B from a third-party reseller. It was roughly $12,000 below the authorized quote from Solta Medical Distribution LLC. The rep told me it was "the same system, just no concierge packaging" and would ship in 6–8 weeks.

It didn't ship in 6–8 weeks. It arrived at week 14, missing key accessories, with no warranty registration (refurb units can't get one), and we spent another three weeks arguing about the missing parts. Total damage: roughly $4,000 in extra costs and a marketing commitment we couldn't honor — we'd already pitched a "Fraxel for acne scars" event to a local physician group before the device was in the building.

I went back and forth between the gray-market savings and the authorized quote for two weeks. Twelve thousand dollars is twelve thousand dollars. Ultimately I chose the cheaper option because the project timeline felt flexible. It wasn't. The event date didn't move, and the device wasn't ready.

What I learned: paying a premium for authorized sourcing and delivery certainty is almost always correct. The "savings" cost me $4,000 extra, three months of lost revenue on that device, and a lot of embarrassment with a referral partner.

Now, for any major device purchase, I only go through authorized channels — Thermage CPT, Fraxel, and Clear+Brilliant all come via Solta Medical Distribution LLC or its certified partners. I budget for the premium. When a clinic expansion or a star injector's start date depends on equipment arriving on a specific week, a written delivery guarantee is worth more than a 10–15% discount.

As of January 2025, authorized pricing on the Thermage CPT TG-2B remains higher than third-party listings. That gap is real. The risk gap is also real. Verify current offers with your Solta rep before committing.

What to choose — scenario-based guidance

This isn't "A is always better." It's about fit:

  • Choose Thermage CPT TG-2B if: your patients skew 40–60 and ask for non-surgical tightening; you have an established facial rejuvenation menu; you can live with a lower per-treatment ticket but higher visit volume.
  • Choose Fraxel if: your patient base includes acne scarring, sun damage, or post-surgical resurfacing demand; you can invest in a longer consultation process; you're prepared for the "will my skin peel?" conversations.
  • Eventually buy both: if demand supports it. Fraxel (texture/scarring/pigment) combined with Thermage (tightening/preventive maintenance) creates higher patient lifetime value. But when the budget only allows one, start with the device your top 20 patients actually ask for by name.

One last thing — if someone offers you a steeply discounted Thermage CPT or Fraxel and claims it's "new, just from a closed clinic's inventory," ask about the warranty registration process before you pay anything. That's where my $4,000 lesson started.

I'm not a dermatologist, so I can't speak to clinical efficacy. What I can tell you from a procurement perspective is how to evaluate the purchase decision without repeating my mistakes.

author-avatar
Jane Smith

I’m Jane Smith, a senior content writer with over 15 years of experience in the packaging and printing industry. I specialize in writing about the latest trends, technologies, and best practices in packaging design, sustainability, and printing techniques. My goal is to help businesses understand complex printing processes and design solutions that enhance both product packaging and brand visibility.

Leave a Reply